Evidence map›Paper›PMID 35637997›Full record

ArticleAnnals of medicine and surgery (2012)2022

Gastrointestinal stromal tumor in the fourth portion of the duodenum does not express the CD117: A case report.

Marouane Harhar, Abdelhakim Harouachi, Nada Akouh, Abderrahmane Atmani, Houssam Aabdi, Tariq Bouhout, Amal Bennani, Badr Serji, Tijani El Harroudi

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. A case report of gastrointestinal stromal tumor of the duodenum.American journal of translational research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Marouane HarharSurgical Oncology Department, Regional Oncology Center, Mohammed VI University Hospital, Oujda, Morocco.
Abdelhakim HarouachiSurgical Oncology Department, Regional Oncology Center, Mohammed VI University Hospital, Oujda, Morocco.
Nada AkouhMohammed First University Oujda, Faculty of Medicine and Pharmacy Oujda, Oujda, Morocco.
Abderrahmane AtmaniSurgical Oncology Department, Regional Oncology Center, Mohammed VI University Hospital, Oujda, Morocco.
Houssam AabdiSurgical Oncology Department, Regional Oncology Center, Mohammed VI University Hospital, Oujda, Morocco.
Tariq BouhoutSurgical Oncology Department, Regional Oncology Center, Mohammed VI University Hospital, Oujda, Morocco.
Amal BennaniMohammed First University Oujda, Faculty of Medicine and Pharmacy Oujda, Oujda, Morocco.
Badr SerjiSurgical Oncology Department, Regional Oncology Center, Mohammed VI University Hospital, Oujda, Morocco.
Tijani El HarroudiSurgical Oncology Department, Regional Oncology Center, Mohammed VI University Hospital, Oujda, Morocco.
Mohamed I University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the digestive tract. Presentation of case: 54-year-old woman with a history of phyllodes tumor of the left breast he patient was admitted to our hospital for management of retroperitoneal soft tissue tumor, attached to the fourth portion of the duodenum, opposite the head of the pancreas. The patient underwent a large excision of the tumor, the duodenojejunal flexure, and the third and fourth portions of the duodenum along with the head of the pancreas. The histopathological examination confirmed the presence of a spindlecell mesenchymal proliferation. These cells do not express CD117, but they express DOG1. A PDGFRA mutation was identified later. The final diagnosis was duodenal GIST. Discussion: few cases of GIST in the fourth portion of the duodenum had been reported in the literature. PDGFRA mutation is identified as GISTs tumorigenesis to 15% of cases, and the diagnosis of GISTs is not based solely on the expression of the protein Kit. Conclusion: the molecular biology examinations are very helpful in the direction of the correct diagnosis in case of negative staining for CD117.

Indexed as

CD117Gastrointestinal stromal tumorsPDGFRA mutationThe fourth portion of the duodenum

Identifiers

PMID35637997
PMCPMC9142376
OpenAlexW4220998900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.